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Abstract
AIM: To evaluate safety and utility of coronary com-
puted tomography angiography (CCTA) compared to 
invasive coronary angiography (ICA) in new cardiomy-
opathy.
METHODS: Eighteen patients (mean age 56.5 years, 
10 males) who presented for evaluation of new onset 
heart failure with evidence of systolic dysfunction (ejec-
tion fraction < 40%) on echocardiography and recent 
ICA were prospectively enrolled. Patients with known 
coronary artery disease, atrial fibrillation, creatinine > 
1.5 g/dL, and contraindication to intravenous contrast 
administration were excluded. CCTA was performed 
using a dual source 64-slice scanner. Mean heart rate 
was 75 beats per minute. Stenosis was graded for each 
coronary segment as: none, mild (< 50%), moderate 
(50%-70%), severe (> 70%), or non-evaluable. Isch-
emic cardiomyopathy (ICM) was diagnosed if severe 
stenosis was present in the left main, proximal left an-
terior descending artery, or two or more major arteries.
RESULTS: Two patients were diagnosed with ICM by 
ICA. CCTA correctly identified 2 patients with ICM and 
16 patients as non-ICM. CCTA successfully evaluated 
240/246 coronary segments with an accuracy of 97.5%, 
sensitivity 70%, specificity 98.7%, positive predictive 
value of 70%, and negative predictive value of 98.7% 
for identifying severe stenosis on a per-segment level. 
CONCLUSION: Dual source 64-slice multi-detector 
CCTA is a safe, accurate, and non-invasive technique 
for diagnosing ICM in patients presenting during the 
acute phase of newly diagnosed cardiomyopathy. 
© 2012 Baishideng. All rights reserved.
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INTRODUCTION
The etiology of  new onset heart failure may be non-
ischemic or related to underlying coronary artery disease 
(CAD) (ischemic) cardiomyopathy Evaluation of  the un-
derlying etiology is important to direct therapeutic strate-
gies and assess prognosis given that an ischemic etiology 
is a significant independent predictor of  worse long-
term outcomes[1,2]. Ischemic cardiomyopathy (ICM) is the 
underlying cause of  heart failure in approximately two-
thirds of  patients[3], and is defined by the presence of  any 
of  the following: (1) history of  myocardial infarction or 
revascularization procedure; (2) ≥ 75% stenosis of  left 
main or proximal left anterior descending artery; or (3) ≥ 
75% stenosis of  two or more epicardial vessels[4]. Clini-
cal assessment of  etiology is unreliable, particularly since 
up to 40% of  patients with a non-ischemic etiology may 
report a history of  typical angina symptoms[4-7]. Thus, 
current guidelines recommend assessment for underlying 
obstructive CAD[8], either through non-invasive testing 
or invasive X-ray coronary angiography (ICA). However, 
traditional noninvasive testing with nuclear imaging and 
echocardiography have not been shown to consistently 
differentiate between ischemic and nonischemic etiolo-
gies[9-18], and patients are frequently referred for ICA.
Coronary computed tomography angiography (CCTA) 
has been demonstrated in several studies to have excellent 
diagnostic accuracy for evaluating the presence of  signifi-
cant CAD[19,20], particularly in unselected populations with 
no known CAD[21]. Patients with heart failure represent 
a unique clinical population for which prior CCTA study 
results are not necessarily applicable. Patients with heart 
failure often have elevated resting heart rates and do not 
tolerate large doses of  β-blocker medications, commonly 
utilized in general CCTA populations to slow the heart 
rate for the purpose of  improving overall image quality 
and increasing the number of  interpretable coronary seg-
ments visualized with CCTA. In addition, left ventricular 
(LV) hemodynamics influence coronary artery opacifica-
tion, and it has been shown that patients with cardio-
myopathy tend to have impaired image quality due to 
reduced contrast opacification compared to patients with 
normal cardiac function[22]. As such, it is often not advis-
able to perform CCTA in the early and acute phase of  
heart failure diagnosis, and studies evaluating the CCTA 
in heart failure patients have performed CCTA during the 
more stable phase after prolonged β-blocker therapy[23,24]. 
We evaluated the safety and diagnostic accuracy of  
CCTA compared to the gold standard of  ICA for evalu-
ating CAD in patients during the acute phase of  newly 
diagnosed cardiomyopathy.
MATERIALS AND METHODS
Study population
We prospectively enrolled 18 patients who presented for 
evaluation of  new onset heart failure symptoms with 
evidence of  systolic dysfunction [ejection fraction (EF) 
< 40%] on echocardiography and recent or planned ICA 
between August 2006 and April 2008. Patients with histo-
ry of  myocardial infarction, prior revascularization, or re-
cent revascularization procedure were excluded from the 
cohort. Patient with contraindications to CCTA including 
history of  severe reaction to iodine contrast, creatinine 
levels < 1.5 mg/dL, and significant cardiac arrhythmia 
were excluded. Patients with intervening clinical event 
between time of  ICA and CCTA were also excluded. 
Our study was approved by the institutional review board 
at the medical center and was compliant with the Health 
Insurance Portability and Accountability Act. All partici-
pating patients gave written informed consent. 
Echocardiography
Clinical 2D and Doppler echocardiography was per-
formed in all patients using standard echocardiographic 
views for quantitative and qualitative assessment of  glob-
al and regional ventricular size and function, increased 
wall thickness and valvular abnormalities. Valvular abnor-
malities were considered significant if  there was evidence 
of  at least moderate stenosis or regurgitation in the aortic 
or mitral valve. Relevant information on overall EF, pres-
ence of  regional vs global wall motion abnormalities, and 
presence of  significant valvular abnormalities was ex-
tracted from the clinical report and verified by a cardiolo-
gist with Level 3 training in echocardiography.
CCTA 
CCTA was performed with a dual source 64-slice scan-
ner (Siemens Definition, Erlangen, Germany). Prior to 
image acquisition, 18- or 20-gauge intravenous access 
was obtained and electrocardiographic (ECG) leads were 
placed. All patients received sublingual nitroglycerin prior 
to scan commencement. Intravenous metoprolol was ad-
ministered to patients with resting tachycardia (heart rate 
> 100 bpm) or frequent premature contractions. A test 
bolus injection method was used to calculate scan delay 
time, and 60-116 mL of  320-370 mg I/mL of  nonionic 
contrast [iodixanol (Visipaque 320, GE Healthcare), io-
pamidol (Isovue 370, Bracco Diagnostics) or iopromide 
(Ultravist 370, Bayer Healthcare Pharmaceuticals)] was 
intravenously administered at a rate of  5-7 mL/s (mean 
6 mL/s) with 50 mL saline chaser. First pass CCTA 
acquisition was obtained from carina through the dia-
phragm using thin collimation in conjunction with ret-
rospective ECG gating. Scan parameters for first pass 
dual source CT scan included gantry rotation 330 ms, 
tube voltage 120 kV for both tubes, average tube output 
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351 mAs (automatically adjusted for patient body habitus 
with CareDose 4D, range 287-426 mAs), retrospective 
gating with pitch automatically adjusted for patient heart 
rate (range 0.2-0.5), ECG dose modulation (using window 
of  30%-80% of  the R-R interval), 32-mm × 2-mm × 
0.6-mm collimation with z-flying focal spot technique and 
82.5 ms temporal resolution. Images were reconstructed 
with 0.75 mm slice thickness and 0.5 mm increment at 
least motion cardiac phases as well as 10% phase intervals 
from 0%-90% of  the RR wave for evaluation of  coronary 
arteries and LV function.
CCTA images were reviewed on a 3D workstation 
equipped with multi-planar and maximum projection ref-
ormations (Multimodality Workplace, Siemens Healthcare) 
by two expert reviewers (MBS, cardiologist with 6 years 
experience and EH, radiologist with 4 years experience) 
blinded to all clinical information and results of  the ICA 
study. Coronary arteries were evaluated using the 15 seg-
ment American Heart Association model of  the coronary 
artery tree[25], and each segment was graded based on 
diameter luminal stenosis severity as follows: 0 = none, 1 
= mild (< 50%), 2 = moderate (50%-70%), 3 = severe (> 
70%), and 4 = non-evaluable. Significant stenoses were 
defined as those with greater than 50% luminal narrow-
ing. Patients were defined as having an ICM by CCTA 
if  there was grade 3 stenosis in the left main, proximal 
left anterior descending artery, or 2 or more major arter-
ies[4]. Additionally, LV end-diastolic volume, end-systolic 
volume and EF were calculated using specialized post-
processing software (Circulation, Siemens Healthcare). 
All coronary artery segments were evaluated regardless 
of  size. 
ICA 
All patients underwent clinically indicated ICA for ev-
aluation of  cardiomyopathy. Conventional ICA was 
performed according to standard clinical protocols[25]. 
Multiple projections were acquired in standard views for 
evaluation of  maximal coronary artery stenosis.
ICA images were reviewed by two expert reviewers 
(JS and ER, cardiologists with 20 and 4 years experience, 
respectively) blinded to all clinical information and results 
of  the CCTA study. The coronary arteries were evalu-
ated in the same manner as the CCTA images utilizing 
the 15 segment coronary segmentation model; coronary 
artery lesions was graded by visual estimation of  percent-
age diameter stenosis. Patients were identified as having 
an ICM by ICA using the same criteria as that used for 
CCTA.
Statistical analysis
Continuous variables were reported as mean and stan-
dard deviation values and compared using the Mann-
Whitney U test, whereas categorical variables were de-
scribed as percentages and compared using Fisher’s exact 
test. The sensitivity, specificity, positive predictive value, 
and negative predictive values were calculated using stan-
dard formulas. Coronary segments that were not evalu-
able by the readers on CCTA secondary to small vessel 
size or coronary motion were removed from analysis. All 
reported P-values are 2-sided and results were declared 
statistically significant when P < 0.05. SPSS Version 18 
statistical software (SPSS Inc., Chicago, IL) was used for 
all computations.
RESULTS
Patient characteristics
There were 18 patients [mean age 56 ± 13 years, 10 (56%) 
men] enrolled who met inclusion and exclusion criteria 
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Table 1  Patient characteristics  n  (%)
All patients (n  = 18) Ischemic (n  = 2) Non-ischemic (n  = 16) P -value
Male sex 10 (56)     2 (100)   8 (50) 0.32
Age (yr)   56 ± 13   67.5 ± 14.8   55.2 ± 12.3 0.86
Hypertension 16 (89)     2 (100) 14 (88) 1.00
Diabetes mellitus   6 (33)     2 (100)   4 (25) 0.10
Hyperlipidemia 11 (61)     2 (100)   9 (56) 0.50
Tobacco use   3 (17) 0 (0)   3 (19) 1.00
Body mass index 27.9 ± 4.5 30.3 ± 5.4 28.3 ± 4.6 0.26
Creatinine clearance   83.5 ± 29.4 60.4 ± 6.6   86.3 ± 29.9   0.052
Baseline medications
   Lasix 13 (72)     2 (100) 11 (69) 1.00
   Beta blocker   18 (100)     2 (100)   16 (100) NS
   ACE inhibitor/angiotensin receptor blocker 17 (94)     2 (100) 15 (94) 1.00
   Aldactone   4 (22) 0 (0)   4 (25) 1.00
   Digoxin   3 (17)   1 (50)   2 (13) 0.31
   Statin use 11 (61)     2 (100)   9 (56) 0.50
   Aspirin 12 (67)     2 (100) 10 (63) 0.53
Echocardiography
   LV EF 22.8 ± 8.6 17.5 ± 3.5 23.4 ± 8.9 0.33
   Regional wall motion abnormalities 12 (67)     2 (100) 10 (63) 0.53
   Valvular abnormalities   6 (33) 0 (0)   6 (38) 0.53
LV: Left ventricle; EF: Ejection fraction; NS: Not significant. 
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(Table 1). Most patients were enrolled within 1 mo (n 
= 10) or 2 mo (n = 16) of  their diagnosis. Two patients 
were enrolled more than 2 mo following initial diagnosis 
and treatment due to timing of  ICA. All patients were 
treated with β-blocker therapy. The majority of  patients 
had already been receiving carvedilol (n = 17) at a rela-
tively small dose (average dose 10.7 ± 7.7 mg twice a 
day). There were a total of  5 patients (28%) with signifi-
cant stenosis in at least 1 coronary segment by ICA. Two 
patients (11.1%) met criteria and were diagnosed with 
ICM. There were no significant differences in the base-
line characteristics between the group with ICM com-
pared to non-ICM (Table 1). 
Echocardiography and ICA comparison
For the two cases of  ICM identified by ICA, echocar-
diography demonstrated regional wall motion abnormali-
ties, normal wall thickness and no evidence for significant 
valvular heart disease, suggestive of  an ICM. Using the 
presence of  regional wall motion abnormalities and no 
significant valvular heart disease as diagnostic criterion 
for ICM, echocardiography demonstrated an accuracy of  
61%, sensitivity 100%, specificity 56%, positive predic-
tive value 22%, and negative predictive value of  100%. In 
the 5 cases with significant stenosis in at least 1 coronary 
segment, echocardiography demonstrated an accuracy of  
56%, sensitivity 60%, specificity 54%, positive predictive 
value 33%, and negative predictive valve of  78% for di-
agnosing significant CAD.
CCTA and ICA safety
All patients received sublingual nitroglycerin 0.4 mg, and 
3 patients received intravenous β-blocker (5 mg maxi-
mum) for frequent premature contractions as part of  
their CCTA examination. No patient received β-blocker 
specifically to lower their heart rate during the examina-
tion. Mean heart rate during CCTA examination was 75 ± 
16 bpm (range 52-101 bpm) and mean intravenous con-
trast amount administered was 91 ± 17 mL (Table 2). All 
patients were in sinus rhythm, although 4 had 1 or more 
premature contractions noted during image acquisition. 
There were no complications or adverse events noted as 
a result of  the CCTA examination. ICA was performed 
via femoral arterial approach for all patients. Mean intrave-
nous contrast amount administered during ICA was 64 ± 
26 mL. There were 2 complications noted after ICA, fem-
oral hematoma and femoral artery dissection, although 
neither complication required further intervention. The 
average time between ICA and CCTA was 31 d (range 
6-74 d).
CCTA and ICA comparison
CCTA correctly identified the two patients with ICM, and 
the remaining patients as having non-ICM (Figures 1 
and 2). Significant differences were noted in the mean 
total calcium score between the ischemic vs non-ICM 
groups (789 vs 57, P < 0.05), however, LV volumes and 
EF were not significantly different (Table 2).
Of  the 246 total coronary segments available for 
analysis, 6 (2.4%) segments were unevaluable by CCTA 
due to small size (mean size 1.4 mm, n = 5) and motion 
artifact (n = 1). Of  the 240 remaining segments, CCTA 
correctly detected significant stenosis in 10 of  16 (62.5%) 
segments identified on ICA as having significant steno-
sis. In the 6 segments with significant stenosis missed by 
CCTA, 5 were in branch vessels or distal segments mea-
suring 1.7 mm or less in diameter, including the posterior 
descending artery (n = 2), obtuse marginal branch (n = 2) 
and diagonal branch (n = 1). Overall, CCTA had an accu-
racy of  96.7%, sensitivity 62.5%, specificity 99.1%, posi-
tive predictive value 83.3%, and negative predictive value 
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Table 2  Coronary computed tomography angiography pa-
rameters
All patients  
(n  = 18)
Ischemic 
(n  = 2)
Non-ischemic 
(n  = 16)
P -
value
Sublingual 
nitroglycerin
18 (100)     2 (100) 16 (100) NS
Intravenous β-blocker 3 (17) 0 (0) 3 (19) 1.00
Contrast amount   91 ± 17   81 ± 15   93 ± 17 0.33
Contrast rate      6 ± 0.5   5.5 ± 0.7   6.1 ± 0.4 0.33
Average heart rate   75 ± 16   68 ± 11   76 ± 16 0.64
Calcium score   138 ± 330   789 ± 839     57 ± 114 0.03
LV EDV 198 ± 87 163 ± 47 203 ± 91 0.72
LV EF   37 ± 19 17 ± 4   40 ± 19 0.09
LV:Left ventricle; EDV: End diastolic volume; EF: Ejection fraction; NS:
Not significant.
Figure 1  A 78-year-old man with dilated cardiomyopathy associated with 
severe coronary artery disease. Curved reformations of the coronary com-
puted tomography angiography images (top) and corresponding X-ray coronary 
angiography images (bottom) are shown for the left anterior descending (LAD), 
left circumflex (LCX) and right coronary artery (RCA). Focal areas of severe 
stenoses (short arrows) are noted in the LAD and RCA.
LAD LCX RCA
LAD
LCX
RCA
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of  97.4% for identifying significant stenosis (> 50%) on 
a per-segment basis. When a > 70% diameter stenosis 
criterion was used, CCTA had an accuracy of  97.5%, sen-
sitivity 70%, specificity 98.7%, positive predictive value 
of  70%, and negative predictive value of  98.7%.
DISCUSSION
This study demonstrates that 64-slice dual source CCTA 
can provide a safe, accurate, and non-invasive technique 
for diagnosing ICM in patients presenting for evalua-
tion of  new cardiomyopathy during the acute phase of  
management and treatment, and with better diagnostic 
performance characteristics compared with resting 2D 
echocardiography. Although 3 of  the patients received 
intravenous β-blocker prior to image acquisition, there 
were no adverse events or complications as a result of  
medication or contrast administration. In this small study, 
CCTA accurately identified the 2 patients with ICM and 
16 patients with non-ICM. Although the mean total cal-
cium score was significantly different between the two 
groups (789 vs 57), our study population was too small to 
evaluate the overall diagnostic value of  a calcium score 
cut-off  value for distinguishing between the two groups. 
However, other studies have demonstrated modest sen-
sitivity (80%-85%) when using calcium score cut point 
values of  45-310[26,27]. Diagnostic accuracy, sensitivity and 
negative predictive values were high for CCTA detection 
of  significant and severe coronary stenoses on a per-
segment level. Compared to prior studies of  CCTA for 
detection of  CAD, our diagnostic sensitivity was rela-
tively lower, primarily related to missed lesions in branch 
vessels or distal coronary segments. As all coronary artery 
segments were evaluated on CCTA regardless of  size, our 
lower sensitivity may have been related to inclusion of  
small vessels that would have been excluded from prior 
studies due to small size < 1.5 mm and/or impaired im-
age quality due to reduced contrast opacification of  these 
smaller segments as a result of  the patient’s underlying 
cardiomyopathy. 
In contrast to prior studies in cardiomyopathy pa-
tients, the majority of  patients in our cohort underwent 
CCTA during a more acute phase (< 2 mo) of  diagnosis 
and treatment. This was reflected by the relatively higher 
average heart rate noted in our study population (mean 
75 ± 16 bpm, range 52-101 bpm) compared to prior 
studies where the heart rate was notably lower, often < 
65 bpm during the time of  image acquisition[23,24,28]. As 
demonstrated by prior studies, pharmacologic reduction 
of  heart rate to < 70 bpm improves image quality and 
diagnostic accuracy[23,24,28]. However, in the more acute 
phase of  cardiomyopathy, elevated heart rate serves as 
a compensatory mechanism for the low stroke volume. 
Thus, aggressive pharmacologic measures to reduce the 
heart rate may be detrimental to a patient’s hemodynamic 
status and are often ineffective. The results of  our study 
further demonstrate the utility of  CCTA in the evalua-
tion of  newly diagnosed cardiomyopathy patients during 
a more acute phase of  diagnosis and treatment despite 
these potential challenges to image quality. 
The main limitations of  this study are the small sam-
ple size and single center experience. Additional CCTA 
studies of  cardiomyopathy patients are needed to further 
demonstrate feasibility and reliability in all stages of  heart 
failure diagnosis.
In conclusion, our preliminary experience shows that 
64-slice, dual source CCTA is a safe, accurate, and useful 
tool for the diagnosis of  ICM in patients during the acute 
phase of  evaluation for new onset cardiomyopathy. 
COMMENTS
Background
Patients with heart failure represent a unique clinical population with elevated 
heart rates and poor left ventricular (LV) hemodynamics for which prior coro-
nary computed tomography angiography (CCTA) study results are not neces-
sarily applicable. It is often not advisable to perform CCTA in the early and 
acute phase of heart failure diagnosis. However, early and accurate diagnosis 
of significant coronary artery disease (CAD) is important to direct management 
in these patients. We demonstrate that dual source 64-slice multi-detector 
CCTA is a safe, accurate, and non-invasive technique for diagnosing ischemic 
cardiomyopathy (ICM) in patients presenting during the acute phase of newly 
diagnosed cardiomyopathy.
Research frontiers
New developments in CCTA have focused on techniques to improve image 
quality and reduce radiation dose for a wide variety of patients undergoing ex-
amination. In particular, dual-source CT systems offer significant improvements 
in temporal resolution, allowing for diagnostic image quality without the need for 
β-blocker use in most patients.
Innovations and breakthroughs
Patients with heart failure often have elevated resting heart rates and poor LV 
hemodynamics which tends to impair image quality, but do not tolerate large 
doses of β-blockers. As such, it is often not advisable to perform CCTA in the 
early and acute phase of heart failure diagnosis, and studies evaluating the 
CCTA in heart failure patients have performed CCTA during the more stable 
phase after prolonged β-blocker therapy. However, early and accurate diag-
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Figure 2  A 58-year-old woman with dilated cardiomyopathy with no sig-
nificant coronary artery disease. Curved reformations of the coronary com-
puted tomography angiography images (top) and corresponding X-ray coronary 
angiography images (bottom) are shown for the left anterior descending (LAD), 
left circumflex (LCX) and right coronary artery (RCA).
LAD LCX RCA
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nosis of significant CAD is important to direct management in these patients. 
The use of dual source CCTA may provide a safe and reliable method for non-
invasive imaging of the coronary arteries in patients with acute heart failure.
Applications
Dual source CCTA may provide a safe and reliable method for distinguishing 
between ischemic and non-ICM during the acute phase of presentation, and 
therefore direct further downstream management strategies. 
Peer review
The manuscript is interesting and of timely manner.
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